相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
Deborah Rudin et al.
EXPERIMENTAL NEUROLOGY (2021)
Designer drugs: mechanism of action and adverse effects
Dino Luethi et al.
ARCHIVES OF TOXICOLOGY (2020)
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2020)
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2020)
Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice
Adam L. Halberstadt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives)
Dino Luethi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?
Matthieu Colom et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines
Karolina E. Kolaczynska et al.
FRONTIERS IN PHARMACOLOGY (2019)
Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
Dino Luethi et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
Dino Luethi et al.
NEUROPHARMACOLOGY (2018)
Pharmacological profile of mephedrone analogs and related new psychoactive substances
Dino Luethi et al.
NEUROPHARMACOLOGY (2018)
Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors
Amy J. Eshleman et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of N-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor Agonist
Anders A. Jensen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Modern Clinical Research on LSD
Matthias E. Liechti
NEUROPSYCHOPHARMACOLOGY (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1
Linda D. Simmler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Receptor interaction profiles of novel N-2-methoxybenzyl (NSOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
Anna Rickli et al.
NEUROPHARMACOLOGY (2015)
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2014)
Extensive Rigid Analogue Design Maps the Binding Conformation of Potent N-Benzylphenethylamine 5-HT2A Serotonin Receptor Agonist Ligands
Jose I. Juncosa et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Fluorine in psychedelic phenethylamines
Daniel Trachsel
DRUG TESTING AND ANALYSIS (2012)
Cardiovascular toxicity of novel psychoactive drugs: Lessons from the past
Patrick Dawson et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
Adam L. Halberstadt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Irving Page Lecture: 5-HT2A serotonin receptor biology: Interacting proteins, kinases and paradoxical regulation
Bryan L. Roth
NEUROPHARMACOLOGY (2011)
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
Florent G. Revel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Psychedelics and the Human Receptorome
Thomas S. Ray
PLOS ONE (2010)
Drug-induced Valvulopathy: An Update
Chandikumar S. Elangbam
TOXICOLOGIC PATHOLOGY (2010)
The Expanded Biology of Serotonin
Miles Berger et al.
ANNUAL REVIEW OF MEDICINE (2009)
4-Aryl-Substituted 2,5-Dimethoxyphenethylamines: Synthesis and Serotonin 5-HT2A Receptor Affinities
Daniel Trachsel et al.
CHEMISTRY & BIODIVERSITY (2009)
Drug-induced fibrotic valvular heart disease
Sanjeev Bhattacharyya et al.
LANCET (2009)
Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment
Xi-Ping Huang et al.
MOLECULAR PHARMACOLOGY (2009)
Structure-activity correlations for β-phenethylamines at human trace amine receptor 1
Anita H. Lewin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands
Matthew A. Parker et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
5-Hydroxytryptamine (5HT)-induced valvulopathy: Compositional. valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats
Chandikumar S. Elangbam et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2008)
Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro
Stephane Doly et al.
JOURNAL OF NEUROSCIENCE (2008)
Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases
John A. Allen et al.
NEUROPHARMACOLOGY (2008)
Trace amine-associated receptor 1 modulates dopaminergic activity
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease
Steven Droogmans et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1
David B. Wainscott et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Differential phospholipase C activation by phenylalkylamine serotonin 5-HT2A receptor agonists
JC Parrish et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Synthesis of novel (phenylalkyl)amines for the investigation of structure-activity relationships. Part 2. 4-thio-substituted [2-(2,5-dimethoxyphenyl)ethyl]amines (=2,5-dimethoxybenzeneethanamines)
D Trachsel
HELVETICA CHIMICA ACTA (2003)
Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists
JJ Chambers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
1-[4-(3-phenylalkyl)phenyl]-2-aminopropanes as 5-HT2A partial agonists
CS Dowd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
